ID: ALA4228360

Max Phase: Preclinical

Molecular Formula: C60H104N20O17

Molecular Weight: 1377.62

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)COCCOCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)O)[C@@H](C)O

Standard InChI:  InChI=1S/C60H104N20O17/c1-7-35(4)49(79-53(90)40(18-13-22-67-59(63)64)74-45(83)30-69-47(85)33-97-26-25-96-24-21-62)57(94)72-31-46(84)75-43(28-38-15-9-8-10-16-38)56(93)78-42(27-34(2)3)55(92)77-41(19-14-23-68-60(65)66)54(91)80-50(37(6)81)58(95)73-36(5)51(88)76-39(17-11-12-20-61)52(89)71-29-44(82)70-32-48(86)87/h8-10,15-16,34-37,39-43,49-50,81H,7,11-14,17-33,61-62H2,1-6H3,(H,69,85)(H,70,82)(H,71,89)(H,72,94)(H,73,95)(H,74,83)(H,75,84)(H,76,88)(H,77,92)(H,78,93)(H,79,90)(H,80,91)(H,86,87)(H4,63,64,67)(H4,65,66,68)/t35-,36-,37+,39-,40-,41-,42-,43-,49-,50-/m0/s1

Standard InChI Key:  ZLZFLEBVJNCCPC-HTBJJKQGSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 1377.62

Molecular Weight (Monoisotopic): 1376.7888

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Stallivieri A, Colombeau L, Devy J, Etique N, Chaintreuil C, Myrzakhmetov B, Achard M, Baros F, Arnoux P, Vanderesse R, Frochot C..  (2018)  New photodynamic molecular beacons (PMB) as potential cancer-targeted agents in PDT.,  26  (3): [PMID:29338907] [10.1016/j.bmc.2017.12.034]

Source

Source(1):

• Scientific Literature